# CNPLE Cram V2 — Parity Batch 43B Clinical Second Pass

Date: 2026-08-09
Scope: `43b-renal-urology-completion-parity.json`
Result: **PASS — clinical authoring second pass**

## Exact identity contract

- `np-benign-prostatic-hyperplasia-management`
- `np-urinary-incontinence-evaluation-and-treatment`
- `np-overactive-bladder-management`
- `np-erectile-dysfunction-evaluation-and-treatment`
- `np-prostatitis-diagnosis-and-management`
- `np-testicular-disorders-evaluation`
- `np-renal-imaging-interpretation`
- `np-urinalysis-in-renal-disease`
- `np-acid-base-disorders-evaluation`

All IDs are literal slugs emitted by the canonical NP parity generator.

## Clinical review

### BPH / male LUTS
PASS. LUTS is treated as a syndrome rather than an automatic BPH diagnosis. Retention, infection, hematuria, neurologic disease, medication contributors and concerning prostate features are assessed before therapy. Symptom-relief versus progression-prevention goals are distinguished.

### Urinary incontinence / OAB
PASS. Stress, urgency, overflow, mixed and functional patterns are separated. Post-void residual is used when retention risk makes it meaningful. Antimuscarinic cognitive/constipation/retention burden and beta-3 agonist blood-pressure considerations are explicit.

### Erectile dysfunction
PASS. ED is treated as a vascular/endocrine/neurologic/medication/psychosexual syndrome and potential cardiovascular risk clue. Nitrate–PDE5 inhibitor co-administration is explicitly contraindicated and cardiovascular stability is considered before treatment.

### Prostatitis
PASS. Acute bacterial prostatitis is separated from chronic bacterial disease and chronic pelvic pain syndrome. Sepsis, retention and abscess are escalation triggers; repeated empiric antibiotics without infection evidence are rejected.

### Testicular/scrotal disorders
PASS. Sudden unilateral scrotal pain is torsion until excluded. Urine testing or ultrasound does not delay urgent urologic/surgical action when the clinical presentation is highly suspicious. Persistent painless masses receive malignancy evaluation.

### Renal imaging
PASS. Modality is selected from the clinical question rather than by habit. Ultrasound, noncontrast CT and contrast CT/MRI roles are separated, and obstructed infected systems retain urgent source-control priority.

### Urinalysis
PASS. Dipstick, microscopy, protein quantification and clinical syndrome are integrated. Pyuria/bacteriuria is not equated with UTI, and active nephritic sediment/proteinuria/AKI triggers renal evaluation.

### Acid–base disorders
PASS. Interpretation follows primary process → expected compensation → anion gap where appropriate → mixed-disorder assessment. Near-normal pH is not treated as proof of normal physiology, and bicarbonate is not taught as a universal treatment for acidemia.

## Canadian source refresh

Load-bearing source families rechecked on 2026-08-09:

- Canadian Urological Association guideline/resources for male LUTS/BPH and current urologic education.
- Canadian urology/functional-urology principles for incontinence, overactive bladder, erectile dysfunction and prostatitis.
- Choosing Wisely Canada Urology/Nephrology/Radiology recommendations.
- Canadian acute-care/urologic practice for torsion and obstructed infection.
- Canadian nephrology/critical-care acid–base practice and Diabetes Canada hyperglycemic-emergency guidance.

Where a current national Canadian CPG does not prescribe one universal operational threshold, the content remains principle-based and explicitly specialist/local-protocol aware.

## Authoring gates

- Required Cram fields: present in all nine.
- Canadian/SI framing: PASS.
- US-only exam/regulatory framing: none intentionally authored.
- Unsupported universal imaging/procedure/medication thresholds: none.
- Red flags/escalation: present in all nine.

## Completion note

With 42A, 43A and 43B, every Renal/Urology concept emitted by `generate-np-parity-expansion-catalog.mjs` now has a dedicated CNPLE Cram authoring identity.

## Publication boundary

Clinical authoring second pass only. Manifest registration, current Full-source anchoring, Bottom Line evidence, three eligible Quick Checks, runtime recipe integrity, learner rendering, merge and deployment remain downstream fail-closed gates.
